GBC-HpVac SA

Swiss Biotech Association

Member

GBC-HpVac is currently developing a revolutionary treatment for allergic diseases such as atopic dermatitis, allergic asthma, food allergies and hay fever based on the discovery that a bacterium present in the human stomach produces a protein that protects us from these diseases.

http://www.hpvac.ch

Location

Avenue de Sécheron 15, 1202 Geneva, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2016
Number of employees in Switzerland

1-9

Key business

Core competencies

Therapeutics/vaccines (human)

You may also be interested in

Tenpoint Therapeutics GmbH

Tenpoint is a biotechnology company committed to advancing engineered cell-based therapies and in vivo reprogramming to restore vision for people with degenerative ocular diseases, bringing together the global experts shaping the regenerative ocular medicine revolution.
4051 Basel

Member

Oncodesign Services

Oncodesign Services is a leading CRO specializing in drug discovery and preclinical services in oncology, inflammation and infectious diseases, through integrated capabilities in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, and in vitro/in vivo pharmacology.
21000 Dijon

Member

Recolony AG

Recolony focuses on the development of cancer therapies based on microbial-derived products. These drugs have an enormous influence on our immune system, enhancing an immune reaction against cancer. With this approach, Recolony will develop a new class of drugs for the treatment of cancer.
Zürich

Member